机译:MiR-505通过靶向HMGB1作为胃癌进展中的肿瘤抑制剂
Department of Rehabilitation Zhejiang Provincial People's Hospital People's Hospital of Hangzhou;
Department of Pharmacy Huai'an Second People's Hospital The Affiliated Huai'an Hospital of Xuzhou;
Department of Clinical Laboratory Center Central Hospital of Enshi Autonomous Prefecture Enshi;
Division of Gastrointestinal Surgery Department of General Surgery Huai'an Second People's;
gastric cancer; high‐mobility group box 1; miR‐505;
机译:MiR-505通过靶向HMGB1作为胃癌进展中的肿瘤抑制剂
机译:雄激素诱导的miR-27A通过靶向MAP2K4和介导的前列腺癌进展而起到抑癌作用
机译:miR-598通过靶向IGF-1R充当人类胃癌的肿瘤抑制因子
机译:Mortalin-Bcl-2相互作用充当癌细胞中的肿瘤抑制机制
机译:谴责作为胃癌中肿瘤抑制和候选生物标志物的作用
机译:通过靶向HMGB1诱导内质网应激MiR-34c在非小细胞肺癌中起抑癌作用
机译:> MIR-34C通过靶向HMGB1(靶向)通过诱导内质网胁迫作为非小细胞肺癌中的肿瘤抑制剂。